Researchers at the Mount Sinai School of Medicine have developed a new nanotechnology-based immunotherapy that promotes long-term transplant acceptance in an animal model.
The development, which is described in the journal Immunity, could transform patient care and provide a solution to the problems that stand in the way of successful transplant outcomes.
If this can be successfully translated to the clinic, this may eliminate the need for lifelong, continuous immunosuppressive medication and provide a promising solution for successful organ transplantation”
Jordi Ochando, study author
A transplanted organ is rejected by the body when innate immune cells called myeloid cells induce T-cells to attack it. To prevent this immune response, patients must take drugs that suppress this T-cell activity, but this dampening down of the patient’s immune system leaves them vulnerable to infection and cancer. The patients also have to take more than a dozen pills every day for the remainder of their lives.
Now, Ochando and colleagues have developed a nano-immunotherapy that targets myeloid cells and prevents their activation and their triggering of T-cells. The T-cells are unaffected by the therapy and maintain their usual function, but without attacking the transplanted organ.
News This Week
Nearly a third of physicians will be sued at least once in their careers — most commonly for an error in diagnosis. Medical errors are also the third-leading cause of death in the United [...]
Inventors and scientists have been continuously working towards reducing the size of technological components. Room-sized computers to laptops that are slimmer than a pane of glass? It’s done. Huge bulky telephones to smartphones that [...]
You have witnessed a variety of nano-devices that were designed for tasks including delivering medicines within the body. All of them used to move in a variety of ways. However, the latest nano-device is [...]
Netra Rajesh is an undergraduate Engineering Science student specializing in Biomedical Systems Engineering. She is currently on her Professional Experience Year (PEY) at the Massachusetts Institute of Technology where her research lies at the [...]
Nearly half of the companies in Europe that call themselves AI start-ups don't in fact use artificial intelligence, a new report found. The research, published Tuesday by London-based venture capital firm MMC Ventures, found [...]
A new quantum sensor developed by researchers at the University of Waterloo's Institute for Quantum Computing (IQC) has proven it can outperform existing technologies and promises significant advancements in long-range 3D imaging and monitoring [...]
Summary: Researchers use nanotech to enhance vision in mice, enabling them to see infrared light as well as visible light. Source: Cell Press. Mice with vision enhanced by nanotechnology were able to see infrared [...]
Immune Aspects of Biopharmaceuticals and Nanomedicines Available from CRC Press 1st Edition Raj Bawa, Janos Szebeni, Thomas J Webster, Gerald F. Audette The enormous advances in the immunology of biotherapeutics and nanomedicines in the [...]
Artificial Intelligence - Ethics, Governance and Policy Challenges by Andrea Renda and CEPS Think Tank released. About the report: CEPS is launching a Task Force to try to bring back the AI debate to [...]
The Nanofacturing consortium has worked on a pan-European nanopharmaceutical project to develop new manufacturing methods and improve supply chain co-ordination to advance treatments for rare cancers, autoimmune diseases and viral infections. The Nanofacturing collaboration [...]
You know those little motes or floaters you that you sometimes see moving in your vision? Well, someday very soon, those could be robots. An international team of medical researchers has unveiled a new [...]
Scientists at the Helmholtz Zentrum München, a partner in the German Center for Lung Research, have presented a new imaging method in the scientific journal ACS Nano ("Three-Dimensional Quantitative Co-Mapping of Pulmonary Morphology and [...]